# FDA Inspection 893095 - Carter BloodCare - HEB - August 28, 2014

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare-heb/2f9705e2-b693-4699-956a-d313d19c19f8
Source feed: FDA_Inspections

> FDA Inspection 893095 for Carter BloodCare - HEB on August 28, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 893095
- Company Name: Carter BloodCare - HEB
- Inspection Date: 2014-08-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1164289 - 2022-03-07](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-heb/0aadc457-1cb9-4235-9533-87c20c014c90)
- [FDA Inspection 1164289 - 2022-03-07](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-heb/e5f68550-c6a3-44c3-944e-c41514669a85)
- [FDA Inspection 1048147 - 2018-04-06](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-heb/3fe0e92d-9aa2-418c-8524-0a6e1f3e3153)
- [FDA Inspection 989470 - 2016-09-14](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-heb/44373595-dfbd-4b23-9d84-3b87555c5d0f)
- [FDA Inspection 849745 - 2013-09-27](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-heb/777c5734-d16d-42c9-8f90-097b32f42a17)

Company: https://www.keypedia.com/companies/carter-bloodcare-heb/4055dff7-addd-4dcd-9a6e-d1434792814e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
